VICTOR PINOS

Dr. VICTOR PINOS


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VPVICTOR PINOS
VICTOR PINOS
JVJorge Vasconez-Gonzalez
Jorge Vasconez-Gonzalez
Juan S. Izquierdo-CondoyJuan S. Izquierdo-Condoy
Juan S. Izquierdo-Condoy
BPBelén Pazmiño
Belén Pazmiño
JVJenny Marisol Sánchez Villarroel
Jenny Marisol Sánchez Villarroel
EOEsteban Ortiz-Prado
Esteban Ortiz-Prado
Minoxidil is a well-established treatment for hair loss, known for its vasodilatory properties and effects on dermal papilla cells. Recently, interest has emerged regarding its potential role in promoting nail growth, both in healthy individuals and in those with nail dystrophies. The objective of this review was to synthesize and critically analyze the available evidence on the effects of topical and oral minoxidil on nail growth, including proposed mechanisms of action, clinical outcomes, and safety. A narrative literature review was conducted using studies published in indexed journals that evaluated the pharmacological effects of minoxidil on the nail unit. Mechanistic data were extracted from in vitro and in vivo models, while clinical results were compiled from pilot studies, case reports, and trials evaluating nail growth in both healthy and pathologic conditions. Proposed mechanisms include vasodilation, increased VEGF expression, and hypothesized involvement of pro-growth pathways (e.g., Wnt/β-catenin), largely extrapolated from hair follicle biology; direct nail-matrix-specific mechanistic evidence remains limited. Clinical studies with 5% topical minoxidil have shown increases in nail growth rate ranging from 13% to 19% over 28 days, while oral minoxidil (2.5 mg) resulted in an approximately 50% increase in nail growth speed in small studies. Evidence also suggests improvements in nail strength and appearance. Adverse effects were minimal, with no significant changes in blood pressure and only modest increases in heart rate with oral formulations. Although evidence remains limited, preliminary findings suggest a potential role for minoxidil in enhancing nail growth, particularly in cases of slowed growth or nail dystrophy. More robust, large-scale studies are needed to confirm efficacy, determine optimal formulations, and establish long-term safety. Given its accessibility and tolerability, minoxidil may represent a promising off-label adjunct for nail growth modulation.

29 April 2023 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
MPMariana Perez
Mariana Perez
NWNatalie Williams
Natalie Williams
AAAlejandra Avila
Alejandra Avila
RBRenato Bakos
Renato Bakos
FBFlavia Bittencourt
Flavia Bittencourt
NJNatalia Jaimes
Natalia Jaimes
Citation: Perez M, Williams NM, Avila AM, et al. Dermoscopy in Selected Latin American Countries: A Preliminary Look into Current Trends and Future Opportunities among Dermatology Residency Programs. Dermatol Pract Concept. 2023;13(2):e2023093. DOI: https://doi.org/10.5826/dpc.1302a93 Accepted: October 19, 2022; Published: April 2023 Copyright: ©2023 Perez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Natalia Jaimes, MD, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Sylvester Comprehensive Cancer Center, Miami, FL. University of Miami Miller School of Medicine, Dermatology Research Clinic 1600 NW 10th Ave. RSMB 2023A, Miami, FL 33136 Phone: 305-243-6735 Email: njaimes@med.miami.edu Introduction: Dermoscopy is a useful technique that aids in early detection of skin cancer by increasing diagnostic accuracy with adequate training. However, dermoscopy is not uniformly taught to residents worldwide. Dermoscopy training in Latin American dermatology residency programs has not been explored. Objectives: To assess current dermoscopy training among dermatology residency programs in Latin America (e.g. training modalities, preferred/most effective modalities per residents, diseases/pathologies taught). Methods: Cross-sectional survey distributed via email between March and May 2021. Chief residents from Argentina, Brazil, Colombia, Costa Rica, Chile, Ecuador, Guatemala, Mexico, Panama, and Uruguay were invited to participate. Results: 81 chief residents completed the questionnaire (81/126, 64.2%). 72% of programs had an established dermoscopy curriculum, with dedicated hours of training varying greatly by program. Institutions commonly utilized sessions with “unknown” dermoscopy images and direct teaching by experts in the clinical setting as supplements to lectures, also described by residents as most effective. The most commonly taught methods included pattern analysis (74.1%), the two-step algorithm (61.7%), and the ABCD rule (59.3%). Almost all respondents reported desiring additional training during residency and believe that dermoscopy training should be a requirement to graduate from residency. Conclusion: This study highlights the current landscape in dermoscopy training among dermatology residency programs in Latin America, demonstrating room for improvement and standardization in dermoscopic education and training. Our results serve as a baseline reference and provide valuable information to guide future educational initiatives incorporating successful teaching strategies (e.g. spaced education/repetition, flipped classroom model) used in dermatology and other fields. Keywords : Dermoscopy, Dermatology Residency, Latin America, Medical Education This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.